Article Text

Download PDFPDF
CASE REPORT
Development of acquired haemophilia A in a patient treated with alemtuzumab for multiple sclerosis
  1. Jarrett Madeley1,
  2. Georgina Hodges2,
  3. Andrew Birchley2
  1. 1Department of Haematology, Cairns Hospital, Cairns, Queensland, Australia
  2. 2Department of Haematology, Townsville Hospital, Townsville, Queensland, Australia
  1. Correspondence to Dr Jarrett Madeley, jarrett.madeley{at}gmail.com

Footnotes

  • Contributors All listed authors provided significant contributions to the conception, design, acquisition, analysis and interpretation of the data. JM was responsible for the majority of drafting with input from GH and AB particularly for ongoing revisions. Final approval was given by all contributing authors for submission for publication. All listed authors agree to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of the work are appropriately investigated and resolved.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Patient consent Obtained.

  • Provenance and peer review Not commissioned; externally peer reviewed.

View Full Text

Statistics from Altmetric.com

Footnotes

  • Contributors All listed authors provided significant contributions to the conception, design, acquisition, analysis and interpretation of the data. JM was responsible for the majority of drafting with input from GH and AB particularly for ongoing revisions. Final approval was given by all contributing authors for submission for publication. All listed authors agree to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of the work are appropriately investigated and resolved.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Patient consent Obtained.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.